Latest stories on TVRD
Lucid Capital Markets initiates Tvardi stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Tvardi Therapeutics assumed with a Buy at Lucid Capital
The Fly61 · neutralanalyst
Tvardi Therapeutics to Participate in Upcoming Investor Events
GlobeNewswire56 · neutralgeneral
Tvardi Therapeutics to Participate in Upcoming Investor Events
StockTitan56 · neutralgeneral
Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript
Seeking Alpha56 · neutralproduct/pr
Tvardi Therapeutics reports Q2 EPS (69c), consensus (63c)
The Fly52 · neutralearnings
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Tvardi Therapeutics GAAP EPS of -$0.69 misses by $0.06
Seeking Alpha34 · bearishearnings
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
Business Insider56 · neutralearnings
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
GlobeNewswire56 · neutralearnings
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
Business Insider63 · neutralproduct/pr
Tvardi Therapeutics Expands At-The-Market Equity Program
TipRanks28 · bearishgeneral
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Why Is Penny Stock Tvardi Therapeutics (TVRD) Up Today?
TipRanks67 · bullishanalyst
Tvardi’s TTI-109 Phase 1 Data Shows Up to 60% Immune Cell Reduction and Superior Tolerability Over TTI-101
MarketChameleon67 · bullishproduct/pr
TTI-109 Phase 1 Results Show Meaningful Reductions in STAT3-Driven Immune Cells—Path Cleared for Dermatologic and GI Trials Pending Funding
MarketChameleon67 · bullishproduct/pr
Tvardi Therapeutics Reports Phase 1 Data for TTI-109
TipRanks63 · neutralproduct/pr
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Tvardi Therapeutics, Inc. (TVRD) files 8-K
SEC 8-K50 · neutralgeneral
Ocugen, Assertio among healthcare stocks set to join Russell Microcap; Definium Therapeutics, Tvardi Therapeutics to exit
Seeking Alpha50 · neutralgeneral
Tvardi Therapeutics to Participate in Upcoming Investor Events | TVRD Stock News
StockTitan56 · neutralgeneral